Form 3 Filing for Indaptus Therapeutics, Inc. - Initial Statement of Beneficial Ownership

This filing is an initial statement of beneficial ownership (Form 3) for Indaptus Therapeutics, Inc. (INDP). The reporting owner is Lu Qinglai, identified by CIK 0002127285, who is a director at the company. The address provided is C/O Indaptus Therapeutics, Inc., 3 Columbus Circle, 15th Floor, New York, NY 10019. The filing indicates that Lu Qinglai has no securities owned as of the period of report, April 8, 2026. The signature date was April 20, 2026.